PPT-IPF SUBSETS Venerino Poletti

Department of Diseases of the Thorax Ospedale GB Morgagni Forlì I Department of Respiratory Diseases amp Allergy Aarhus University Hospital Aarhus DK. Case Presentation: Familial IPF. 56-year-old Hispanic female with a family history of aortic aneurysm underwent a routine chest CT to assess her aorta. No respiratory symptoms. Medical history . h/o SVT. (ILD). Mike McFarlane (CT1). 12/5/12. SLIME. What we’ll cover. Definition. Different types of ILD. Pathophysiology. Presentation. Investigations. Management. Prognosis. Clinical Scenario. Summary. What we won’t.... Trials and Treatments. Craig Thurm, MD. Director, Pulmonary Medicine. Director, Pulmonary Fellowship. Medical Director. , . Respiratory . Care. Jamaica Hospital Medical Center. Disclosure of Relevant . Diagnosis and Monitoring. Kevin R. Flaherty, MD, . MS.  . Associate Professor. Pulmonary and Critical Care Medicine. University of Michigan Health System. Ann Arbor, Michigan. Faculty Disclosure. . PULMONARY FIBROSIS MANAGEMENT STRATEGIES I. NOVEMBER 13, 2015. Managing comorbidity. Disclosures. . Scientific Advisory Board and speaker’s fees. Biogen. Idec, . Boehringer. . Ingelheim. ,. Gilead, . PULMONARY FIBROSIS MANAGEMENT STRATEGIES I. NOVEMBER 13, 2015. Pharmacologic therapy. Disclosures. Research Grants. Roche (. InterMune. ). Scientific Advisory Board . Roche (. InterMune. ). Boehringer. ICS 6D. Sandy . Irani. Two Different Counting Problems. Student council has 15 members. Must select officers (. Pres. , VP, Treasurer, Secretary. ). Sample selection: (Sally, Frank, Margaret, George). Educational Activity Learning Objective. Upon completion of this course, the participants should be able to:. Explain the considerations associated with clinical evaluation, imaging, and surgical . biopsy . Discussing Prognosis &. Goals of Care. Sonye K. . Danoff. , MD, . PhD. PULMONARY FIBROSIS. : WHAT AND . WHY. November 13, 2015. No conflict of interest relevant to this presentation. Objective of this talk. . Content. Importance. . of. . early. . diagnosis. . Initial . clues. . to. . suspect. IPF . Guidelines for Diagnosis. Diagnostic algorithm for IPF. . Exclusion of other known causes . Other tests and tools . Diagnosing Idiopathic Pulmonary Fibrosis. FACULTY. Title. Affiliation. Learning Objectives. Explain the considerations associated with . clinical evaluation, imaging, and . biopsy. , in terms of differentially diagnosing . IPF. S2k-Leitline basiert. Präsentation im Rahmen von AT8 Ausbildung Mai 2019. . I. diopathische. . p. ulmonale . F. ibrose. . was ist das eigentlich?. Langsam fortschreitende Erkrankung des Lungeninterstitiums. January 2021. Summary - orvepitant first in class/category, novel treatment for debilitating chronic cough associated with the terminal orphan condition idiopathic pulmonary fibrosis. The NeRRe management team recently sold KaNDy Therapeutics to Bayer in a deal valued >$1b. When using our slides, please retain the source attribution:. These slides may not be published, posted online, or used in commercial presentations without permission. . Please contact . pce@practicingclinicians.com.